Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $5.39 Million - $6.47 Million
-39,000 Reduced 91.33%
3,700 $598,000
Q3 2022

Oct 25, 2022

BUY
$134.21 - $153.93 $1.11 Million - $1.28 Million
8,300 Added 24.13%
42,700 $5.73 Million
Q2 2022

Aug 01, 2022

SELL
$137.62 - $174.96 $4.1 Million - $5.21 Million
-29,800 Reduced 46.42%
34,400 $5.27 Million
Q1 2022

Apr 27, 2022

BUY
$131.98 - $163.75 $8.47 Million - $10.5 Million
64,200 New
64,200 $10.4 Million
Q4 2021

Jan 31, 2022

SELL
$107.43 - $135.93 $3.89 Million - $4.92 Million
-36,200 Closed
0 $0
Q3 2021

Nov 02, 2021

BUY
$106.4 - $120.78 $2.9 Million - $3.3 Million
27,300 Added 306.74%
36,200 $3.91 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $841,680 - $937,680
8,000 Added 888.89%
8,900 $1 Million
Q1 2021

May 03, 2021

SELL
$102.3 - $112.62 $30,690 - $33,786
-300 Reduced 25.0%
900 $98,000
Q4 2020

Jan 29, 2021

BUY
$80.49 - $108.67 $96,588 - $130,404
1,200 New
1,200 $129,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Qvr LLC Portfolio

Follow Qvr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qvr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qvr LLC with notifications on news.